Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Novak

Showing results (631-640 of 826) with videos related to

Pageof 83
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Phase II study of vinorelbine in patients with androgen-independent prostate cancerS Oudard, A Caty, Y Humblet, et al.
Cancer Research|April 23, 2009
Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphomaAnne J Novak, Susan L Slager, Zachary S Fredericksen, et al.
Bioinformatics (Oxford, England)|August 30, 2014
RVboost: RNA-seq variants prioritization using a boosting methodChen Wang, Jaime I Davila, Saurabh Baheti, et al.
Blood|July 15, 2009
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disordersRyan A Wilcox, Andrew L Feldman, David A Wada, et al.
Nature Genetics|April 1, 1996
Ocular retardation mouse caused by Chx10 homeobox null allele: impaired retinal progenitor proliferation and bipolar cell differentiationM Burmeister, J Novak, M Y Liang, et al.
Leukemia|April 28, 2023
Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphomaTheodora Anagnostou, Zhi-Zhang Yang, Shahrzad Jalali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphomaJacob P Smeltzer, Jason M Jones, Steven C Ziesmer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2022
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and HumansHeather Eng, Alyssa L Dantonio, Eugene P Kadar, et al.
Cytokine|September 27, 2012
Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control studyBridget Charbonneau, Matthew J Maurer, Stephen M Ansell, et al.
American Journal of Hematology|March 28, 2019
The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomasSean I Tracy, Melissa C Larson, Andrew L Feldman, et al.
Pageof 83

Showing results (631-640 of 826) with videos related to

Sort By:
Pageof 83
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Phase II study of vinorelbine in patients with androgen-independent prostate cancerS Oudard, A Caty, Y Humblet, et al.
Cancer Research|April 23, 2009
Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphomaAnne J Novak, Susan L Slager, Zachary S Fredericksen, et al.
Bioinformatics (Oxford, England)|August 30, 2014
RVboost: RNA-seq variants prioritization using a boosting methodChen Wang, Jaime I Davila, Saurabh Baheti, et al.
Blood|July 15, 2009
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disordersRyan A Wilcox, Andrew L Feldman, David A Wada, et al.
Nature Genetics|April 1, 1996
Ocular retardation mouse caused by Chx10 homeobox null allele: impaired retinal progenitor proliferation and bipolar cell differentiationM Burmeister, J Novak, M Y Liang, et al.
Leukemia|April 28, 2023
Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphomaTheodora Anagnostou, Zhi-Zhang Yang, Shahrzad Jalali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphomaJacob P Smeltzer, Jason M Jones, Steven C Ziesmer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2022
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and HumansHeather Eng, Alyssa L Dantonio, Eugene P Kadar, et al.
Cytokine|September 27, 2012
Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control studyBridget Charbonneau, Matthew J Maurer, Stephen M Ansell, et al.
American Journal of Hematology|March 28, 2019
The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomasSean I Tracy, Melissa C Larson, Andrew L Feldman, et al.
Pageof 83